Smith Karen L.

CIK 000163963711 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001639637

Recent Transactions

50 trades

Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2025-06-12+123,500→ 123,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2025-06-12+50,000→ 50,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2025-06-12+25,000→ 102,100 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2025-02-24+35,000→ 35,000 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Director Stock Option (right to buy)
2024-11-21+18,641→ 18,641 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Shares
2024-11-21+12,135→ 24,807 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2024-11-11$8.43/sh−5,241→ 12,672 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Units
2024-11-08−17,913→ 0 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2024-11-08+17,913→ 17,913 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2024-10-28+70,000→ 70,000 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2024-09-04+19,315→ 19,315 total
Award
Skye Bioscience, Inc.$SKYE
Director Stock Option (Right to Buy)
2024-07-02+40,000→ 40,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2024-06-04+50,000→ 50,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2024-06-04+25,000→ 77,100 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2023-08-18+28,959→ 28,959 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Units
2023-08-18+17,913→ 17,913 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-06-13+20,500→ 20,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2023-06-01+27,750→ 27,750 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2023-06-01+13,900→ 52,100 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2023-02-01+225,000→ 225,000 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-06-09+14,501→ 14,501 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−46,729→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Common Stock
2022-05-24$5.60/sh−25,452→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Common Stock
2022-05-24$5.60/sh−54,193→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−58,246→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−20,000→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−48,542→ 0 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2022-05-23+1,365,449→ 1,365,449 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2022-05-19+151,799→ 151,799 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-05-19+24,336→ 24,336 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-05-19+170,354→ 194,690 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-05-16+29,002→ 29,002 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2022-02-25+25,000→ 25,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2022-02-25+12,500→ 38,200 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−4,085→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−3,222→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−3,750→ 0 total
Disposition from Tender
ACCELERON PHARMA INC
Common Stock
2021-11-19−1,622→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−1,875→ 0 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-06-10+48,542→ 48,542 total
Award
ANTARES PHARMA, INC.
Common Stock
2021-06-10$4.42/sh+25,452→ 79,645 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2021-05-07$60.85/sh−305→ 11,888 total
Sale
ACCELERON PHARMA INC
Common Stock
2021-04-05$141.15/sh−641→ 1,622 total
Exercise/Conversion
ACCELERON PHARMA INC
Common Stock
2021-04-05$52.99/sh+2,050→ 13,486 total
Exercise/Conversion
ACCELERON PHARMA INC
Common Stock
2021-04-05$35.34/sh+5,000→ 9,561 total
Sale
ACCELERON PHARMA INC
Common Stock
2021-04-05$140.13/sh−11,223→ 2,263 total
Exercise/Conversion
ACCELERON PHARMA INC
Common Stock
2021-04-05$41.64/sh+1,875→ 11,436 total
Exercise/Conversion
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-04-05−1,875→ 3,750 total
Exercise/Conversion
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-04-05−5,000→ 10,000 total

Companies

Recent Filings

Address

11250 EL CAMINO REAL SUITE 100

SAN DIEGO, CA, 92130

View on SEC.gov